April 8th 2025
The EMA has issued a new proposal that aims to encourage biosimilar development and improve patient access to biosimilar therapies.
Qualifying Release Laboratories in Europe and the United States
March 1st 2004The European Union requires final container testing of US-manufactured biopharmaceutical products to be performed in Europe for release into the European market. Similarly, but less strictly enforced, the US requires final container testing in the US for European-manufactured biopharmaceutical products before release.